rs104894679
|
|
1.000 |
0.120 |
19 |
46756376 |
missense variant
|
A/G
|
snv
|
6.3E-06
|
|
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 5
|
0.700 |
|
0 |
|
|
rs104894680
|
|
1.000 |
0.120 |
19 |
46756604 |
stop gained
|
C/A;G;T
|
snv
|
4.1E-06;
1.7E-04
|
|
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 5
|
0.700 |
|
0 |
|
|
rs104894681
|
|
0.776 |
0.200 |
19 |
46756793 |
missense variant
|
C/T
|
snv
|
9.0E-06
|
|
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2I
|
0.700 |
|
0 |
|
|
rs104894681
|
|
0.776 |
0.200 |
19 |
46756793 |
missense variant
|
C/T
|
snv
|
9.0E-06
|
|
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 5
|
0.700 |
|
0 |
|
|
rs104894681
|
|
0.776 |
0.200 |
19 |
46756793 |
missense variant
|
C/T
|
snv
|
9.0E-06
|
|
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5
|
0.700 |
|
0 |
|
|
rs104894681
|
|
0.776 |
0.200 |
19 |
46756793 |
missense variant
|
C/T
|
snv
|
9.0E-06
|
|
Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies) Type A, 1
|
0.700 |
|
0 |
|
|
rs104894682
|
|
0.925 |
0.160 |
19 |
46756936 |
stop lost
|
T/A
|
snv
|
8.1E-06
|
1.4E-05
|
Walker-Warburg congenital muscular dystrophy
|
0.700 |
|
0 |
|
|
rs104894682
|
|
0.925 |
0.160 |
19 |
46756936 |
stop lost
|
T/A
|
snv
|
8.1E-06
|
1.4E-05
|
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2I
|
0.700 |
|
0 |
|
|
rs104894689
|
|
1.000 |
0.120 |
19 |
46756214 |
stop gained
|
G/A
|
snv
|
|
|
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2I
|
0.700 |
|
0 |
|
|
rs1060502109
|
|
1.000 |
0.120 |
19 |
46756533 |
stop gained
|
C/A;G
|
snv
|
4.5E-06
|
|
Walker-Warburg congenital muscular dystrophy
|
0.700 |
|
0 |
|
|
rs121908110
|
|
0.882 |
0.160 |
19 |
46756837 |
missense variant
|
A/G
|
snv
|
1.2E-04
|
2.1E-05
|
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 5
|
0.700 |
|
0 |
|
|
rs121908110
|
|
0.882 |
0.160 |
19 |
46756837 |
missense variant
|
A/G
|
snv
|
1.2E-04
|
2.1E-05
|
Muscular Dystrophy
|
0.700 |
|
0 |
|
|
rs1290836394
|
|
1.000 |
0.120 |
19 |
46755605 |
frameshift variant
|
-/TGCGG
|
delins
|
|
|
Walker-Warburg congenital muscular dystrophy
|
0.700 |
|
0 |
|
|
rs1483781400
|
|
1.000 |
0.120 |
19 |
46756381 |
stop gained
|
G/A;T
|
snv
|
|
|
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2I
|
0.700 |
|
0 |
|
|
rs1555735545
|
|
0.851 |
0.160 |
19 |
46746071 |
5 prime UTR variant
|
G/A
|
snv
|
|
|
Arachnodactyly
|
0.700 |
|
0 |
|
|
rs1555735545
|
|
0.851 |
0.160 |
19 |
46746071 |
5 prime UTR variant
|
G/A
|
snv
|
|
|
Creatine phosphokinase serum increased
|
0.700 |
|
0 |
|
|
rs1555735545
|
|
0.851 |
0.160 |
19 |
46746071 |
5 prime UTR variant
|
G/A
|
snv
|
|
|
Chronic fatigue
|
0.700 |
|
0 |
|
|
rs1555735545
|
|
0.851 |
0.160 |
19 |
46746071 |
5 prime UTR variant
|
G/A
|
snv
|
|
|
Memory impairment
|
0.700 |
|
0 |
|
|
rs1555735545
|
|
0.851 |
0.160 |
19 |
46746071 |
5 prime UTR variant
|
G/A
|
snv
|
|
|
Elevated aldolase level
|
0.700 |
|
0 |
|
|
rs1555735545
|
|
0.851 |
0.160 |
19 |
46746071 |
5 prime UTR variant
|
G/A
|
snv
|
|
|
Gait imbalance
|
0.700 |
|
0 |
|
|
rs1555735545
|
|
0.851 |
0.160 |
19 |
46746071 |
5 prime UTR variant
|
G/A
|
snv
|
|
|
Vertigo
|
0.700 |
|
0 |
|
|
rs1555735545
|
|
0.851 |
0.160 |
19 |
46746071 |
5 prime UTR variant
|
G/A
|
snv
|
|
|
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2I
|
0.700 |
|
0 |
|
|
rs1555735545
|
|
0.851 |
0.160 |
19 |
46746071 |
5 prime UTR variant
|
G/A
|
snv
|
|
|
Range of joint movement increased
|
0.700 |
|
0 |
|
|
rs1555735545
|
|
0.851 |
0.160 |
19 |
46746071 |
5 prime UTR variant
|
G/A
|
snv
|
|
|
Palpitations
|
0.700 |
|
0 |
|
|
rs1555735545
|
|
0.851 |
0.160 |
19 |
46746071 |
5 prime UTR variant
|
G/A
|
snv
|
|
|
Hyperextensible skin of face
|
0.700 |
|
0 |
|
|